Clinical Trial Details
— Status: Enrolling by invitation
Administrative data
NCT number |
NCT04132310 |
Other study ID # |
R00HD086304 |
Secondary ID |
|
Status |
Enrolling by invitation |
Phase |
|
First received |
|
Last updated |
|
Start date |
August 21, 2019 |
Est. completion date |
December 31, 2025 |
Study information
Verified date |
May 2024 |
Source |
University of Texas at Austin |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Early life influences (including the intrauterine environment, birth weight, and early
postnatal growth) shape subsequent weight trajectories and future chronic disease risk. The
MINT study will evaluate whether maternal fat mass changes are associated with specific
maternal weight trajectories during pregnancy, and with neonatal adiposity at birth. The
study is a prospective observational cohort currently enrolling women in early pregnancy,and
following mothers and infants after birth.
Description:
The Institute of Medicine (IOM) recommendations were established with limited evidence
showing how the pattern of weight gain is associated with short-and long-term health of
mothers and their children. Previous studies evaluated the impact of overall gestational
weight gain pattern across gestation using latent class analysis and others have evaluated
maternal weight change pattern-by trimester or early/late pregnancy-on offspring size and
adiposity. However, it remains unclear if there are weight gain trajectories or specific
periods of weight gain that are associated with greater adiposity in offspring, and whether
effects persist across the life course.
The MINT study will expand our understanding of determinants that are influencing maternal
weight trajectories, including race/ethnicity, prepregnancy BMI and parity. Although many
factors are well-established determinants of pregnancy weight gain, such as prepregnancy BMI
and parity, there is limited understanding of whether these factors and others, such as
maternal diet, race, psychosocial health or socio-economic status, influence the overall
pattern of pregnancy weight gain and the IOM has called for research in this area. This
knowledge is essential for providing personalized clinical recommendations for weight gain
monitoring and to develop interventions to support healthy weight gain that optimizes health
outcomes for mother and child.
This study is an observational, prospective cohort design, and will recruit up to 60
volunteers with singleton gestations of BMI 18.5-35. The mothers' will be assessed at 14-15,
24-25, and 35 weeks of pregnancy, and at 6 weeks post-delivery. Additional measurements may
also be collected at 6-, 12-, and 24-months postpartum. The measurements will include
anthropometry (weight, height, circumferences, and skin fold thicknesses), and whole body
magnetic resonance imaging (MRI) and/or dual-energy X-ray absorptiometry (DXA). The infants'
measurements will be anthropometry at birth (2-3 days), and approximately 1 and 6 weeks.
Additional measurements may also be collected at 6-, 12-, and 24-months. Infants will also
undergo air displacement plethysmography (PeaPod) at approximately 1 week and 6 weeks, and
potentially DXA at 12- and 24-months. Biospecimen samples will be collected, including:
maternal serum, plasma, urine, microbiome, breastmilk, placenta, umbilical cord and cord
blood, infant meconium and stool, and infant saliva. Data will be collected regarding
mothers' dietary intake and physical activity (questionnaires and accelerometry). Other data
to be collected include questionnaires on quality of life, socio-economic status, health
behaviors and intentions. If the woman identifies a partner, the partner will be invited to
complete questionnaires on health, health behaviors and anthropometry measures.